Replies to post #4364 on Avita Medical Ltd (RCEL)

[Fitz1030]

I liked how Perry revealed that many existing Avita investors (and some new ones) participated in the latest $120mil cap raise at $0.59.

The fact that our cornerstone institutional investors are buying more shares at this level confirms that they have no plans of selling any of their shares around here. I have a feeling the ~30mil AVH shorts are going to get toasted real soon...

[Fmello]

This is the first I am reading about this:

"Vitiligo – we have treated over 1000 patients in China with success and with no failures," Dr Perry said. "We have also had seven publications to support the adoption of Recell for vitiligo."

Isn’t vitiligo a 2 billion dollar market?

[melody432]

Thanks Fitz. The Bell Potter estimates at the bottom of the article appear to be well off. 480 units at 7500 equals 3.6mil sales. But they had US sales of 4.6mil in this last quarter, or over 600 units. We'll see at the end of January, but I'd guess we'll already be in the 8 to 9 hundred unit range for the last quarter of 2019. So next year should be substantially better than his estimate.